
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Epidemiology Biomarkers & Prevention, Vol 3, Issue 2 173-175, Copyright © 1994 by American Association for Cancer Research
ARTICLES |
CB Begg and ZF Zhang
Memorial Sloan-Kettering Cancer Center, Department of Epidemiology and Biostatistics, New York, New York 10021.
The case-series design is being used increasingly to explore associations between environmental risk factors and genetic markers. It is demonstrated that the odds ratio derived from a case-series study is the ratio of the relative risk for developing marker-positive disease to the relative risk for developing marker-negative disease. This parameter is an empirical manifestation of etiological heterogeneity with respect to the risk factor under study, and it can be used to construct a statistical significance test. Presence of etiological heterogeneity, as reflected in departures of this parameter from unity, could be a result of either the presence of distinct causal mechanisms for the two categories of cases, or a different strength of effect via the same mechanism. The case-series approach represents an efficient and valid approach for evaluating gene-environment associations, especially in referral centers where it is difficult to identify a valid control group.
This article has been cited by other articles:
![]() |
N. E. Thomas, S. N. Edmiston, A. Alexander, R. C. Millikan, P. A. Groben, H. Hao, D. Tolbert, M. Berwick, K. Busam, C. B. Begg, et al. Number of Nevi and Early-Life Ambient UV Exposure Are Associated with BRAF-Mutant Melanoma Cancer Epidemiol. Biomarkers Prev., May 1, 2007; 16(5): 991 - 997. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Chiarelli, V. A. Kirsh, N. S. Klar, R. Shumak, R. Jong, E. Fishell, M. J. Yaffe, and N. F. Boyd Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1856 - 1862. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E Kelemen, J. R Cerhan, U. Lim, S. Davis, W. Cozen, M. Schenk, J. Colt, P. Hartge, and M. H Ward Vegetables, fruit, and antioxidant-related nutrients and risk of non-Hodgkin lymphoma: a National Cancer Institute-Surveillance, Epidemiology, and End Results population-based case-control study Am. J. Clinical Nutrition, June 1, 2006; 83(6): 1401 - 1410. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Lim, M. Schenk, L. E. Kelemen, S. Davis, W. Cozen, P. Hartge, M. H. Ward, and R. Stolzenberg-Solomon Dietary Determinants of One-Carbon Metabolism and the Risk of Non-Hodgkin's Lymphoma: NCI-SEER Case-Control Study, 1998-2000 Am. J. Epidemiol., November 15, 2005; 162(10): 953 - 964. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Brooks, J. H.M. Austin, R. T. Heelan, M. S. Ginsberg, V. Shin, S. H. Olson, J. E. Muscat, and S. D. Stellman Influence of Type of Cigarette on Peripheral versus Central Lung Cancer Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 576 - 581. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Tamimi, S. E. Hankinson, H. Campos, D. Spiegelman, S. Zhang, G. A. Colditz, W. C. Willett, and D. J. Hunter Plasma Carotenoids, Retinol, and Tocopherols and Risk of Breast Cancer Am. J. Epidemiol., January 15, 2005; 161(2): 153 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rundle Molecular Epidemiology of Physical Activity and Cancer Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 227 - 236. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. J. Hall, P. G. Moorman, R. C. Millikan, and B. Newman Comparative Analysis of Breast Cancer Risk Factors among African-American Women and White Women Am. J. Epidemiol., January 1, 2005; 161(1): 40 - 51. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Freudenheim, M. Bonner, S. Krishnan, C. B. Ambrosone, S. Graham, S. E. McCann, K. B. Moysich, E. Bowman, T. Nemoto, and P. G. Shields Diet and alcohol consumption in relation to p53 mutations in breast tumors Carcinogenesis, June 1, 2004; 25(6): 931 - 939. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Koushik, R. W. Platt, and E. L. Franco p53 Codon 72 Polymorphism and Cervical Neoplasia: A Meta-Analysis Review Cancer Epidemiol. Biomarkers Prev., January 1, 2004; 13(1): 11 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Furberg, R. C. Millikan, J. Geradts, M. D. Gammon, L. G. Dressler, C. B. Ambrosone, and B. Newman Environmental Factors in Relation to Breast Cancer Characterized by p53 Protein Expression Cancer Epidemiol. Biomarkers Prev., September 1, 2002; 11(9): 829 - 835. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Engel, E. Taioli, R. Pfeiffer, M. Garcia-Closas, P. M. Marcus, Q. Lan, P. Boffetta, P. Vineis, H. Autrup, D. A. Bell, et al. Pooled Analysis and Meta-analysis of Glutathione S-Transferase M1 and Bladder Cancer: A HuGE Review Am. J. Epidemiol., July 15, 2002; 156(2): 95 - 109. [Abstract] [Full Text] [PDF] |
||||
![]() |
N T Brockton UGT1A1 polymorphisms and colorectal cancer susceptibility Gut, June 1, 2002; 50(6): 748 - 749. [Full Text] [PDF] |
||||
![]() |
J. C. Schroeder and C. R. Weinberg Use of Missing-Data Methods to Correct Bias and Improve Precision in Case-Control Studies in which Cases Are Subtyped but Subtype Information Is Incomplete Am. J. Epidemiol., November 15, 2001; 154(10): 954 - 962. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Basham, P. D.P. Pharoah, Catherine.S. Healey, R. N. Luben, N. E. Day, D. F. Easton, B. A.J. Ponder, and A. M. Dunning Polymorphisms in CYP1A1 and smoking: no association with breast cancer risk Carcinogenesis, November 1, 2001; 22(11): 1797 - 1800. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Mitchell, J. C. Murray, S. O'Brien, and K. Christensen Evaluation of Two Putative Susceptibility Loci for Oral Clefts in the Danish Population Am. J. Epidemiol., May 15, 2001; 153(10): 1007 - 1015. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. D. Botto and M. J. Khoury Commentary: Facing the Challenge of Gene-Environment Interaction: The Two-by-Four Table and Beyond Am. J. Epidemiol., May 15, 2001; 153(10): 1016 - 1020. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Thomas, Q. Qin, J. Kuypers, N. Kiviat, R. L. Ashley, A. Koetsawang, R. M. Ray, and S. Koetsawang Human Papillomaviruses and Cervical Cancer in Bangkok. II. Risk Factors for in Situ and Invasive Squamous Cell Cervical Carcinomas Am. J. Epidemiol., April 15, 2001; 153(8): 732 - 739. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Levine and J. Boyd The Androgen Receptor and Genetic Susceptibility to Ovarian Cancer: Results from a Case Series Cancer Res., February 1, 2001; 61(3): 908 - 911. [Abstract] [Full Text] |
||||
![]() |
M. Orjuela, V. P. Castaneda, C. Ridaura, E. Lecona, C. Leal, D. H. Abramson, I. Orlow, W. Gerald, and C. Cordon-Cardo Presence of Human Papilloma Virus in Tumor Tissue from Children with Retinoblastoma: An Alternative Mechanism for Tumor Development Clin. Cancer Res., October 1, 2000; 6(10): 4010 - 4016. [Abstract] [Full Text] |
||||
![]() |
H. E KUPER, L. A MUCCI, and D. TRICHOPOULOS Coffee, pancreatic cancer and the question of causation J. Epidemiol. Community Health, September 1, 2000; 54(9): 650 - 651. [Full Text] |
||||
![]() |
B. K JACOBSEN and I. HEUCH Coffee, K-ras mutations and pancreatic cancer: A heterogeneous aetiology or an artefact? J. Epidemiol. Community Health, September 1, 2000; 54(9): 654 - 655. [Full Text] |
||||
![]() |
M. L. Gillison, W. M. Koch, R. B. Capone, M. Spafford, W. H. Westra, L. Wu, M. L. Zahurak, R. W. Daniel, M. Viglione, D. E. Symer, et al. Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers J Natl Cancer Inst, May 3, 2000; 92(9): 709 - 720. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Marcus, R. B. Hayes, P. Vineis, M. Garcia-Closas, N. E. Caporaso, H. Autrup, R. A. Branch, J. Brockmöller, T. Ishizaki, A. E. Karakaya, et al. Cigarette Smoking, N-Acetyltransferase 2 Acetylation Status, and Bladder Cancer Risk: A Case-Series Meta-analysis of a Gene-Environment Interaction Cancer Epidemiol. Biomarkers Prev., May 1, 2000; 9(5): 461 - 467. [Abstract] [Full Text] |
||||
![]() |
E. Kampman, D.W. Voskuil, A.A. van Kraats, H.F. Balder, G.N.P. van Muijen, R.A. Goldbohm, and P. van't Veer Animal products and K-ras codon 12 and 13 mutations in colon carcinomas Carcinogenesis, February 1, 2000; 21(2): 307 - 309. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-Y. Huang, B. Newman, R. C. Millikan, K. Conway, B. S. Hulka, M. J. Schell, and E. T. Liu Risk of Breast Cancer According to the Status of HER-2/neu Oncogene Amplification Cancer Epidemiol. Biomarkers Prev., January 1, 2000; 9(1): 65 - 71. [Abstract] [Full Text] |
||||
![]() |
S.-M. Hou, D. Ryberg, S. Falt, A. Deverill, T. Tefre, A.-L. Borresen, A. Haugen, and B. Lambert GSTM1 and NAT2 polymorphisms in operable and non-operable lung cancer patients Carcinogenesis, January 1, 2000; 21(1): 49 - 54. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Goldstein and N. Andrieu Detection of Interaction Involving Identified Genes: Available Study Designs J Natl Cancer Inst Monographs, December 1, 1999; 1999(26): 49 - 54. [Abstract] [Full Text] |
||||
![]() |
A. Yngveson, C. Williams, A. Hjerpe, J. Lundeberg, P. Söderkvist, and G. Pershagen p53 Mutations in Lung Cancer Associated with Residential Radon Exposure Cancer Epidemiol. Biomarkers Prev., May 1, 1999; 8(5): 433 - 438. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |